Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
Find out what a historical investment in Pharming Group NV would be worth today using our PHAR stock calculator.
Buying PHAR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Pharming Group NV in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in PHAR
What is the ticker symbol of Pharming Group NV?
The ticker symbol for Pharming Group NV is PHAR.
How much is one share of PHAR?
One share of PHAR is valued at $12.17 as of 20 November 2026.
What is the 52-week high for Pharming Group NV stock?
The Pharming Group NV 52-week high stock price is $21.34.
What is the 52-week low for Pharming Group NV stock?
The Pharming Group NV 52-week low stock price is $9.11.
Can I buy PHAR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PHAR shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PHAR on Stake
Buy PHAR from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of PHAR from only US$10 with fractional shares